**1. Introduction**

140 Steroids – Basic Science

Stewart, P.M. § Sheppard, M.C. (1992). Novel aspects of hormone action: intracellular ligand

Taranger, J., Engström, I., Lichtenstein, H., Svennberg-Redegren, I.VI. (1976). Somatic

Thyen, U., Lanz, K., Holterhus, P.M. § Hiort, O. (2006). Epidemiology and initial

Tong, S.Y., Hutson, J.M. § Watts, L.M. (1996). Does testosterone diffuse down the wolffian duct during sexual differentiation? *Journal of Urology*, 155, pp. 2057–2059. Twesten, W., Holterhus, P., Sippell, W.G., Morlot, M., Schumacher, H., Schenk, B. § Hiort, O.

hydroxysteroid dehydrogenase deficiency. *Hormone Research*, 53, pp. 26–31. Ulloa-Aguirre, A., Bassol, S., Poo, J., Mendez, J.P., Mutchinick, O., Robles, C. § Perez-

Van Poucke, C., Van De Velde, M. § Van Peteghem, C. (2005). Combination of liquid

Whitney, A.R., Diehn, M., Popper, S.J., Alizadeh, A.A., Boldrick, J.C., Relman, D.A. § Brown,

Wiesemann, C., Ude-Koeller, S., Sinnecker, G.H. § Thyen, U. (2010). Ethical principles and

Wu, L., Einstein, M., Geissler, W.M., Chan, H.K., Elliston, K.O. § Andersson, S. (1993).

Wilson, J.D. (1978). Sexual differentiation. *Annual Review of Physiology*, 40, pp. 279–306. Wilson, J.D., Griffin, J.E.§ Russell, D.W. (1993). Steroid 5 alpha-reductase 2 deficiency.

male gender role behavior. *Endocrine Review*, 20(5) pp. 726-737.

promoter in Leydig cells. In: Endocrine, Boston, P1-372.

pubertal development. *Acta Paediatrica Scandiva,* 258, pp. 121-135.

*Endocrinology*, 83(2-3), pp. C13-18.

*Endocrinology § Metabolism*, 60, pp. 639–643.

*Journal of Mass spectrometry,* 40(6), pp. 731-738.

pp.195–203.

671–679

supply and its control by a series of tissue specific enzymes. *Molecular and Cellular* 

management of ambiguous genitalia at birth in Germany. *Hormone Research*, 66,

(2000). Clinical, endocrine, and molecular genetic findings in patients with 17beta-

Palacios, G. (1985). Endocrine and biochemical studies in a 46,XY phenotypically male infant with 17-ketosteroid reductase deficiency. *The Journal of Clinical* 

chromatography/tandemmass spectrometry and gas chromatography/mass spectrometry for the detection of 21 anabolic steroid residues in bovine urine.

P.O. (2003). Individuality and variation in gene expression patterns in human blood. *Proceedings of the National Academy of Sciences USA*, 100, pp.1896–1901.

*Endocrine Review*, 14(5), pp. 577-93. Wilson, J.D. (1999). The role of androgens in

recommendations for the medical management of differences of sex development (DSD)/intersex in children and adolescents. *European Journal of Pediatrics*, 169, pp.

Expression cloning and characterization of human 17 betahydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alphahydroxysteroid dehydrogenase activity. *The Journal of Biological Chemistry*, 268, pp.12964–12969. Xiaofei, D., Rosenfeld, R.L. § Quin, K. (2006). Molecular mechanisms regulating basal

expression of 17 hydroxysteroid dehydrogenase type 3 (HSD17B3) gene
